1Carai MA, Colombo G, Maccioni P, et al. Efficacy of rimonabant and other cannabinoid CB1 receptor antagonists in reducing food intake and body weight: preclinical and clinical data[J]. CNS Drug Rev, 2006, 12(2) : 91-99.
2European Medicines Agency: Press release. European Medicines Agency recommends Acomplia must not be used in patients on antidepressants or with major depression [ EB/OL]. [ 2007-07-19 ]. 2007-09-02. http ://www. emea. europa. eu/humandocs/ PDFs/EPAR/acomplia/32982607 en. pdf.
